PCSK9 and LDLR trafficking in hepatocytes

被引：0
|
作者：
Zhang, Da-Wei [1 ]
Garuti, Rita [1 ]
Lagace, Tom [1 ]
Horton, Jay [1 ]
Cohen, Jonathan C. [1 ]
Hobbs, Helen H. [1 ]
机构：
[1] Univ Texas, SW Med Ctr, Dallas, TX USA
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2007年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E115 / E115
页数：1
相关论文
共 50 条
  • [1] An Allosteric Binding Site on Sortilin Regulates the Trafficking of VLDL, PCSK9, and LDLR in Hepatocytes
    Sparks, Robert P.
    Arango, Andres S.
    Jenkins, Jermaine L.
    Guida, Wayne C.
    Tajkhorshid, Emad
    Sparks, Charles E.
    Sparks, Janet D.
    Fratti, Rutilio A.
    BIOCHEMISTRY, 2020, 59 (45) : 4321 - 4335
  • [2] The cellular trafficking of the secretory proprotein convertase PCSK9 and its dependence on the LDLR
    Nassoury, Nasha
    Blasiole, Daniel A.
    Oler, Angie Tebon
    Benjannet, Suzanne
    Hamelin, Josee
    Poupon, Vivianne
    McPherson, Peter S.
    Attie, Alan D.
    Prat, Annik
    Seidah, Nabil G.
    TRAFFIC, 2007, 8 (06) : 718 - 732
  • [3] Molecular dynamics of PCSK9 trafficking at the Golgi and its effect on LDLR degradation
    Hamouda, H. Ait
    Villeneuve, L.
    Demers, A.
    Mayer, G.
    MOLECULAR BIOLOGY OF THE CELL, 2012, 23
  • [4] Overexpression of Pcsk9 leads to the formation of an LDLR-Pcsk9 complex and acceleration of LDLR degradation
    Maxwell, KN
    Breslow, JL
    CIRCULATION, 2004, 110 (17) : 244 - 244
  • [5] The effect of PCSK9 immunization on the hepatic level of microRNAs associated with the PCSK9/LDLR pathway
    Ataei, Sarina
    Ganjali, Shiva
    Banach, Maciej
    Karimi, Ehsan
    Sahebkar, Amirhossein
    ARCHIVES OF MEDICAL SCIENCE, 2023, 19 (01) : 203 - 208
  • [6] SILENCING OF PCSK9 BY SIRNA-FUNCTIONALIZED RHDL AS TOOL TO UPREGULATE LDLR EXPRESSION IN HEPATOCYTES
    Larrea, A.
    Jebari Benslaiman, S.
    Galicia-Garcia, U.
    Uribe, K. B.
    Benito-Vicente, A.
    Martin, C.
    ATHEROSCLEROSIS, 2022, 355 : E155 - E155
  • [7] Trafficking Dynamics of PCSK9-Induced LDLR Degradation: Focus on Human PCSK9 Mutations and C-Terminal Domain
    Poirier, Steve
    Hamouda, Hocine Ait
    Villeneuve, Louis
    Demers, Annie
    Mayer, Gaetan
    PLOS ONE, 2016, 11 (06):
  • [8] Small Molecule Inhibitors of the PCSK9•LDLR Interaction
    Taechalertpaisarn, Jam
    Zhao, Bosheng
    Liang, Xiaowen
    Burgess, Kevin
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2018, 140 (09) : 3242 - 3249
  • [9] PCSK9 Interaction with LDLR Interferes with Apoe Binding
    Yamamoto, Taichi
    Ryan, Robert O.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (11) : E205 - E205
  • [10] STRUCTURE AND TRAFFICKING OF PCSK9 IN LDL BINDING
    Matteucci, Sara
    Pravata, Valentina
    Esposito, Francesco Maria
    Arnaboldi, Lorenzo
    Gianazza, Erica
    Grigore, Liliana
    Banfi, Cristina
    Catapano, Alberico
    ATHEROSCLEROSIS, 2024, 395
12345